Making the Most of the ASCO Annual Meeting

Slideshow

We present some tips and advice from the editorial board of ONCOLOGY on how to make the most at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, including places to go in Chicago, nice spots at McCormick Place, and some recommended presentations and sessions.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
KIM-1 is a biomarker in the blood that may help noninvasively detect kidney cancer, according to Wenxin (Vincent) Xu, MD.
A phase 0 trial is seeking to assess the feasibility of aiding anti-cancer cells with cytokines to restore their function.
Although pembrolizumab addressed a long-standing need in adjuvant kidney cancer treatment, combinations with the agent may further bolster efficacy.
“The trial will be successful, or [we’ll] declare it a success if we see at least 3 of 24 responses overall,” stated Ravi, MD, BChir, MRCP, on the phase 2 LASER trial in RCC.
Success with the 177Lu-PSMA-617 radioligand therapy would be transformative for the clear cell renal cell carcinoma treatment landscape.
5 experts are featured in this series
4 experts in this video
2 experts are featured in this series.
Related Content